PARKINSONISM SYNDROME FORMATION IN EXPERIMENTAL ANIMALS. NEUROINFLAMMATORY PENUMBRA
Much valuable information about the development of Parkinson’s disease (PD) has been obtained from studies on the laboratory animals. Objectives. To compare the development of neurotoxic and neuroinflammatory parkinsonism syndrome in laboratory animals. Material and methods. The number of rats in th...
Saved in:
| Published in: | Vestnik Vitebskogo gosudarstvennogo medit︠s︡inkogo universiteta Vol. 20; no. 4; pp. 53 - 60 |
|---|---|
| Main Authors: | , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
17-08-2021
|
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Much valuable information about the development of Parkinson’s disease (PD) has been obtained from studies on the laboratory animals. Objectives. To compare the development of neurotoxic and neuroinflammatory parkinsonism syndrome in laboratory animals. Material and methods. The number of rats in the group of neuroinflammatory model of parkinsonism syndrome (lipopolysaccharide) was 6, and in the group of neurotoxic model (rotenone) - 20. The control group consisted of 5 animals. The study was approved by the independent Ethics Committee. The development dynamics of parkinsonism syndrome of neurotoxic and neuroinflammatory genesis was assessed in the study of the motor activity of animals, as well as in the laboratory study of biomarkers of dopamine metabolism (dopamine and homovanillic acid) in blood serum and cerebrospinal fluid obtained in 7 and 21 days after the first administration of rotenone or lipopolysaccharide, and also after a single intravenous injection of allogeneic (rat) multipotent mesenchymal stromal cells (MMSC) carried out after 9 injections of rotenone. Results. A decrease in the levels of dopamine and homovanillic acid has been shown in laboratory animals on the development of Parkinson’s syndrome. In rats with a neuroinflammatory model of parkinsonism syndrome, a pre-motor stage of motor disorders development has been laboratorially confirmed. During the first weeks after the introduction of MMSC, regression of the motor symptoms of neurotoxic parkinsonism syndrome and a parallel increase in dopamine and homovanillic acid are determined. Conclusions. The effectiveness of MMSC in the early post-transplantation period is associated with the paracrine effect. It is proposed to call activated microglia, a potential therapeutic target in PD, neuroinflammatory penumbra. |
|---|---|
| ISSN: | 1607-9906 2312-4156 |
| DOI: | 10.22263/2312-4156.2021.4.53 |